Magnolia Wins First Phase of Patent Trial on Kurin Sepsis Tests

Kurin Inc.’s collection sets for blood-infection tests infringe a Magnolia Medical Technologies Inc. patent for medical devices used in blood draws, a federal jury in Delaware ruled Tuesday in the first verdict of a two-phase trial.

Magnolia proved that Kurin’s blood culture collection sets that include the Kurin Lock device literally infringe the only two claims of the patent that remained at issue, according to a verdict on Tuesday in the US District Court for the District of Delaware. The trial began July 22 in Wilmington.

Jurors deliberated for less than an hour before reaching the verdict, which triggered ...